Return to ads
All categories


Posted by
Posting ads for 49 years
� "Stocks that Standout" picks for today are: JDSU, MNTX, OCLSThu.

May 28, 2009; Posted: 03:41 AM Are you looking to increase your ETF knowledge? May 28, 2009 (M2 PRESSWIRE via COMTEX) -- OCLS | Quote | Chart | News | PowerRating -- "Stocks that Standout" picks for today are: JDSU (NASDAQ: JDSU), Manitex International, Inc.

(NASDAQ: MNTX), Oculus Innovative Sciences, Inc.

(NASDAQ: OCLS)...and Proudly Introducing Proprietary Push Technology (PPT).

The Newest and Revolutionary Technology for Increasing Investor Visability.

REAL Awareness for REAL Companies.

Click below for a full demonstration. Sign-up for our FREE Stock Alerts AND AWARD WINNING NEWSLETTER at May 27, 2009 -- JDSU (NASDAQ: JDSU; and TSX: JDU) today announced Just-Proof (J-Proof) testing for its T-BERD/MTS transport network test products, the T-BERD(R)/MTS-6000A Multi-Services Application Module and T-BERD/MTS-8000 Transport Module.

With J-Proof testing, the industry's first of its kind, carriers can ensure the expedient turn-up of carrier-grade Ethernet circuits with quality of service (QoS) and Service Level Agreements (SLAs) in environments that employ third-party networks.

Designed for technicians who troubleshoot and turn-up end-to-end Ethernet circuits, JDSU's J-Proof testing verifies transparent forwarding of Ethernet frames over switched Ethernet networks.

When Ethernet passes over switched Ethernet networks, improperly configured network elements (routers, switches, etc.) can filter or even drop critical network transmissions, causing hours of troubleshooting and turn-up delays.

Delays are further complicated when they occur over third party networks, and by using J-Proof, carriers can confidently test that their Ethernet traffic passes through networks end-to-end - including third-party networks - and that they do not have to build their networks from scratch.

"To make Ethernet carrier-grade, Ethernet control plane messages must be reliably exchanged between all equipment regardless of where on the circuit the equipment is located," said Jim Nerschook, vice president and general manager in JDSU's Communications Test and Measurement business segment.

"With the J-Proof feature set, JDSU inspires this confidence and solidifies its position as the vendor of choice for next-generation packet optical network testers that enable a quick return on capital investment, reduce mean time to repair and simplify testing - helping reduce overall operational expenses and increase revenue." Features in the J-proof Test Option include Ethernet frame transparency testing over VLAN and Q-in-Q; VLAN Priority setting to ensure control messages do not time out or get dropped; Cisco Proprietary Protocol Test to verify commonly-used Cisco VTP and CDP end-to-end; and GARP and STP tests that confirms registration and topology protocols.

A powerful user interface with both easy Pass/Fail and granular results helps technicians quickly evaluate test results as well as troubleshoot problems, reducing operational expense.

With field applications for servicing Metro Core telecom networks, wireless/cable switch centers and backhaul networks, government telecommunications and network equipment manufacturer field installation and support groups, JDSU T-BERD/MTS Transport test solutions offer NEMs and service providers worldwide the confidence to successfully build, deploy, and manage Ethernet and Business Class solutions.

JDSU offers a single-source Carrier Ethernet test portfolio that facilitates analysis of all seven layers of Metro Ethernet services.

The JDSU portfolio provides the industry's deepest set of test features in an integrated, end-to-end approach to testing Metro Ethernet products and services, including lab and service verification, development and production, installation and maintenance, troubleshooting and overall service assurance.

About JDSU JDSU enables broadband and optical innovation in the communications, commercial and consumer markets.

JDSU is the leading provider of communications test and measurement solutions and optical products for telecommunications service providers, cable operators, and network equipment manufacturers.

JDSU is also a leading provider of innovative optical solutions for medical/environmental instrumentation, semiconductor processing, display, brand authentication, aerospace and defense, and decorative applications.

May 27, 2009 -- Manitex International, Inc.

(NASDAQ: MNTX), a leading provider of engineered lifting solutions including boom truck cranes, rough terrain forklifts and special mission-oriented vehicles announced today that it received new orders valued at approximately $7 million.

The orders consisted of commercial boom truck cranes for the owner-operated and rental markets of approximately $5 million and a new order for Manitex Liftking military container handling forklifts valued at approximately $2 million from a United States government agency.

The Company expects to ship these orders by the end of 2009.

"Manitex International has a unique, diverse, and high quality product portfolio, consisting of specialized products that deliver a healthy return on investment and cash flow for its customers," commented Andrew Rooke, President and Chief Operating Officer.

"Our niche strategy and focus have positioned us well to win new business in our target markets.

Liftking has a positive history with military orders, and the recent increase in the military orders we have received is particularly encouraging." "Manitex Liftking container handling forklifts possess innovative features that meet strict military standards and perform in almost any terrain," said Bob Litchev, Senior Vice President of Manitex International, Inc.

"This repeat order features custom-built specifications and demonstrates the military's continued acceptance of, and commitment to, Manitex Liftking's high-quality products." Manitex Liftking's forklifts are built to exacting military standards including compliance with the quality controls required by ISO 9001.

Before being shipped, each machine is thoroughly tested on a military approved endurance track located adjacent to Manitex Liftking's military vehicle manufacturing plant.

There are a limited number of test tracks in North America and having a military approved test track is an advantage.

The U.S.

Department of Defense alone has hundreds of Manitex Liftking vehicles serving the Navy, Army and Air Force that they depend on daily.

About Manitex International, Inc.

Manitex International, Inc.

is a leading provider of engineered lifting solutions including cranes, rough terrain forklifts, indoor electric forklifts and special mission oriented vehicles, including parts support.

Our Manitex subsidiary manufactures and markets a comprehensive line of boom trucks and sign cranes through a national and international dealership network.

Our boom trucks and crane products are primarily used in industrial projects, energy exploration and infrastructure development, including roads, bridges, and commercial construction.

Our Crane and Machinery division is a Chicago based distributor of cranes including Terex truck and rough terrain cranes, Fuchs material handlers and our own Manitex product line.

Crane and Machinery provides after market service in its local market as well as being a leading distributor of OEM crane parts, supplying parts to customers throughout the United States and internationally.

Our Manitex Liftking subsidiary is a provider of material handling equipment including the Noble straight-mast rough terrain forklift product line, Lowry high capacity cushion tired forklift and Schaeff electric indoor forklifts as well as specialized carriers, heavy material handling transporters and steel mill equipment.

Manitex Liftking's rough terrain forklifts are used in both commercial and military applications.

May 27, 2009 -- Oculus Innovative Sciences, Inc.

(NASDAQ: OCLS), a healthcare company that develops, manufactures and markets a family of products based upon the Microcyn(R) Technology platform, today announced that it has received 510(k) clearance from the U.S.

Food and Drug Administration (FDA) to market its Microcyn(R) Skin and Wound Gel as both a prescription and over-the-counter formulation.

The Rx product, under the supervision of a health care professional, is intended for management of exuding wounds such as leg ulcers, pressure ulcers, diabetic ulcers and for the management of mechanically or surgically debrided wounds.

This is the first hydrogel product based upon the Microcyn Technology platform and is reimbursable by both Medicare and Medicaid.

The original Microcyn-based solution, branded as Microcyn Wound Care in the United States, Microdacyn60(TM) in Mexico, Dermacyn(TM) Wound Care in Europe and China and Oxum in India, has treated over one million patients worldwide without a report of a single serious adverse effect.

"We are pleased to receive FDA clearance for this Microcyn hydrogel product," said Hoji Alimi, founder and CEO of Oculus.

"We understand the critical role that reimbursement plays in the successful commercialization of a medical product, and in that this is our first reimbursable product, we plan to aggressively market to the U.S.

healthcare community.

At the same time, we are taking all steps necessary to secure regulatory approvals outside North America so as to begin generating international sales through our existing distribution channels worldwide." Oculus, in partnership with its North American contract sales organization, Advocos, will market and sell the Microcyn(R) Skin and Wound Gel to the North American medical community as well as consumers beginning in June 2009.

About Oculus Oculus Innovative Sciences develops, manufactures and markets a family of products based upon the Microcyn(R) Technology platform, which includes new formulations designed to significantly reduce the need for antibiotics as it reduces infections.

The Microcyn Technology platform features a biocompatible, shelf-stable solution that is currently commercialized in the United States, Europe, India, China and Mexico and select Middle East countries.

Several solutions derived from this platform have demonstrated, in a variety of research and investigational studies, the ability to treat a wide range of pathogens, including antibiotic-resistant strains of bacteria (including MRSA and VRE), viruses, fungi and spores, increase blood flow to the wound site, reduce both inflammation and pain while assisting in faster wound closure.

The company's headquarters are in Petaluma, California, with operations in Europe and Latin America.

About has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies. email report service is free to those investors who sign up on our website.

The alert service is designed to notify investors of undervalued and often overlooked stocks.

Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market.

To subscribe to this free service, visit the Standout StocksReport home page at and select the "join now" button.

Join us at for a complimentary subscription to the most exciting online financial newsletter on the market.

Disclaimer: Verify all claims and do your own due diligence. profiles are not a solicitation or recommendation to buy, sell or hold securities. is not offering securities for sale.

An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved.

All statements and expressions are the sole opinion of the editor and are subject to change without notice. is not liable for any investment decisions by its readers or subscribers.

It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies.

The information contained herein has been provided as an information service only.

The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained.

It should be understood there is no guarantee that past performance will be indicative of future results.

Investors are cautioned that they may lose all or a portion of their investment in this or any other company.

In order to be in full compliance with the Securities Act of 1933, Section 17(b), is owned and operated by

Neither nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents.

Since receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in statements and opinions and such statements and opinions cannot be considered independent. and its management may benefit from any increase in the share prices of the profiled companies.

Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements".

Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. services are often paid for using free-trading shares. may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

Visit us for a full Disclaimer at: CONTACT: e-mail: [email protected] ((M2 Communications disclaims all liability for information provided within M2 PressWIRE.

Data supplied by named party/parties.

Further information on M2 PressWIRE can be obtained at on the world wide web.

Inquiries to [email protected]

For full details on JDS Uniphase Corp (JDSU) click here.

JDS Uniphase Corp (JDSU) has Short Term PowerRatings of 3.

Details on JDS Uniphase Corp (JDSU) Short Term PowerRatings is available at This Link.

���� More News:�� Market Updates | Stock Alerts | All Trading News | Stock IndexEmailPrintArchivesFeedbackEmail Article LinkClose XRecipients email addressYour nameYour email Add a note (optional)
Reply to this ad
Recently viewed ads
Saved ads
Please log in to browse your saved adverts or sign up if you don't have an account yet.
Popular Stuff